Form 4 for STE Steris
Accepted 2023-06-02 00:00:00 ET · period of report 2023-05-31 · accession 0001209191-23-033773 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-02 | 2023-05-31 | STE | Fraser Mary Clare | SVP, Chief HRO | A - Grant | $0.00 | +2,313 | 9,564 | +32% | $0 |
| D | 2023-06-02 | 2023-05-31 | STE | Fraser Mary Clare | SVP, Chief HRO | A - Grant | $0.00 | +13.0K | 13.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-05-31 | A | A | 2,313 | $0.00 | 9,564 | D | — | — | (F1) As of May 31, 2023, 8,451 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 791 on June 1, 2023; 791 on June 1, 2024; 1,836 on June 2, 2025; 692 on October 1, 2025; 2,313 on June 1, 2026 and 2,028 on June 2, 2026. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-05-31 | A | A | 12,984 | $0.00 | 12,984 | D | $219.97 · — to 2033-05-31 | 12,984 Ordinary Shares | (F2) This option becomes exercisable as follows: 3,246 on May 31, 2024; 3,246 on June 2, 2025; 3,246 on June 1, 2026 and 3,246 on June 1, 2027. |